Marshall Wace, LLP Omeros Corp Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Omeros Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 44,205 shares of OMER stock, worth $371,764. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,205Holding current value
$371,764% of portfolio
0.0%Shares
10 transactions
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $528M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...